Current Pharmaceutical Biotechnology
Title:Foreword (“New Targets and New Drugs: from in silico Planning to in vivo Testing”)
Volume: 14 Issue: 5
Author(s): Giovanni Maga
Affiliation:
Export Options
About this article
Cite this article as:
Maga Giovanni, Foreword (“New Targets and New Drugs: from in silico Planning to in vivo Testing”), Current Pharmaceutical Biotechnology 2013; 14 (5) . https://dx.doi.org/10.2174/138920101405131111103331
DOI https://dx.doi.org/10.2174/138920101405131111103331 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Azoles in Pharmacochemistry: Perspectives on the Synthesis of New Compounds and Chemoinformatic Contributions
Current Pharmaceutical Design Antitubercular Properties of Substituted Hydroxycyclohexadienones
Letters in Drug Design & Discovery Cystic Hygroma with Multiple Benign Bone Lymphangiomas in an Adult Patient: A Rare Entity in the Differential Diagnosis of Multiple Osseous Lesions in Oncology Practice
Current Medical Imaging Inhibitors of Types I and II Dehydroquinase
Mini-Reviews in Medicinal Chemistry Microbial Interactions in Plants: Perspectives and Applications of Proteomics
Current Protein & Peptide Science Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Current Pharmaceutical Design Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial (Hot Topic: Proteolytic Inhibitors: Implications on Microorganisms Development, Virulence and Pathogenesis)
Current Medicinal Chemistry Inhibition of Drug Efflux in Mycobacteria with Phenothiazines and Other Putative Efflux Inhibitors
Recent Patents on Anti-Infective Drug Discovery Chemotherapeutic Strategies Against Trypanosoma brucei: Drug Targets vs. Drug Targeting
Current Pharmaceutical Design Multiscale Mapping of AIDS in U.S. Countries vs Anti-HIV Drugs Activity with Complex Networks and Information Indices
Current Bioinformatics New insights on Ethambutol Targets in Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Current Pharmaceutical Design Fungal Zinc Homeostasis – A Tug of War Between the Pathogen and Host
Current Medicinal Chemistry An Integrated Re-Annotation Approach for Functional Predictions of Hypothetical Proteins in Microbial Genomes
Current Bioinformatics Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Recent Advances in Multidimensional QSAR (4D-6D): A Critical Review
Mini-Reviews in Medicinal Chemistry Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design Cytokine Therapies in Crohns Disease: Where are We Now and where should We Go?
Inflammation & Allergy - Drug Targets (Discontinued)